Breanna Beers

Breanna Beers

Auto-generated profile, based on publicly available information

Breanna Beers

Postbaccalaureate Fellow/National Institute of Allergy and Infectious Diseases, National Institutes of Health

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 May 2023 in Clinical Immunology
Verified
Journal Article
Closed access
BBBreanna Beers
Breanna Beers
HDHannah Davidson
Hannah Davidson
KLKatie Lewis
Katie Lewis
MSMichael Setzer
Michael Setzer
MWMagdalena Walkiewicz
Magdalena Walkiewicz
MSMorgan Similuk
Morgan Similuk

1 January 2019 in Bioethics in Faith and Practice
Verified
Journal Article
Open access
BBBreanna Beers
Breanna Beers

23 May 2023 in Clinical Immunology
Verified
Journal Article
Closed access
BBBreanna Beers
Breanna Beers
MSMorgan Similuk
Morgan Similuk
RGRajarshi Ghosh
Rajarshi Ghosh
BSBryce Seifert
Bryce Seifert
WCWenjia Cao
Wenjia Cao
JYJia Yan
Jia Yan

23 November 2022 in Research Square
Verified
Preprint
Open access
PDF file
BBBreanna Joy Beers
Breanna Joy Beers
MSMorgan Similuk
Morgan Similuk
RGRajarshi Ghosh
Rajarshi Ghosh
BSBryce A. Seifert
Bryce A. Seifert
LJLeila Jamal
Leila Jamal
JYJia Yan
Jia Yan
Purpose: Though copy number variants (CNVs) have been suggested to play a significant role in inborn errors of immunity (IEI), the precise nature of this role remains largely unexplored. Thus, we sought to determine the diagnostic contribution of CNVs using genome-wide chromosomal microarray analysis (CMA) in children with suspected or known IEI. Methods: We performed exome sequencing (ES) and CMA for 332 unrelated pediatric probands referred for evaluation of IEI. The analysis included primary, secondary, and incidental findings. Results: Of the 332 probands, 134 (40.4%) received molecular diagnoses. Of these, 116/134 (86.6%) were diagnosed by ES alone. An additional 15/134 (11.2%) were diagnosed by CMA alone, including two likely de novochanges. Three (2.2%) participants had diagnostic molecular findings from both ES and CMA, including two compound heterozygotes and one patient with two distinct diagnoses. Half of the participants with CMA contribution to diagnosis had CNVs in at least one non-immune gene, highlighting the clinical complexity of these cases. Overall, CMA contributed to 18/134 diagnoses (13.4%), increasing the overall diagnostic yield by 15.5%. Conclusion: Pairing ES and CMA can provide a comprehensive evaluation to clarify the complex factors that contribute to both immune and non-immune phenotypes. Such a combined approach to genetic testing helps untangle complex phenotypes, not only by clarifying the differential diagnosis, but in some cases by identifying multiple diagnoses contributing to the overall clinical presentation.

1 January 2026 in Case Reports in Genetics
Verified
Journal Article
Open access
BBBreanna Beers
Breanna Beers
HWHamilton Wexler
Hamilton Wexler
GMGretchen MacCarrick
Gretchen MacCarrick
Marfan syndrome (MFS) is an autosomal dominant connective tissue disorder caused by pathogenic variants in the fibrillin‐1 ( FBN1 ) gene on Chromosome 15q21.1. A 3‐year‐old female presented to the clinic with MFS and a family history of an affected maternal uncle and maternal great‐aunt. The proband and the uncle had a positive thoracic aortic aneurysm and dissection (TAAD) panel for MFS revealing an FBN1 deletion. This was confirmed on proband’s chromosome microarray; however, the mother was negative for the FBN1 deletion. Fluorescence in situ hybridization (FISH) was used in this case to show a unique chromosome rearrangement in the unaffected mother with an insertional translocation of the 15q21.1 loci ( FBN1 ) to Chromosome 7p. This led to an affected child who inherited the nontranslocated Chromosome 7 and the 15q21 ( FBN1 ) deletion. Thus, individuals in the family inheriting Chromosome 7 with the FBN1 insertional translocation are protected from the MFS phenotype. This supports the known autosomal dominant inheritance pattern while allowing for uncharacteristic skipping of generations of MFS in this family.